Psivant Therapeutics has a differentiated pipeline of targets with high biological and disease validation that have historically provided challenges for the design of therapeutics.
Psivant Therapeutics has a differentiated pipeline of targets with high biological and disease validation that have historically provided challenges for the design of therapeutics.
Dual WEE1/MYT1 Inhibitor
Focus: Oncology
Status: Discovery
Dual IRAK1/IRAK4 Inhibitor
Focus: Inflammation
Status: Discovery
Allosteric Inhibitor
Focus: Inflammation and Immunology
Status: Discovery
Allosteric Inhibitor
Focus: Inflammation and Immunology
Status: Discovery
Allosteric Inhibitor
Focus: Inflammation and Immunology
Status: Discovery
Allosteric Inhibitor
Focus: Inflammation and Immunology
Status: Exploratory
Target Animations by Istvan Kolossvary